Welcome to LookChem.com Sign In|Join Free

CAS

  • or

103-46-8

Post Buying Request

103-46-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103-46-8 Usage

Description

(Benzylthio)acetic acid, also known as 2-(benzylthio)acetic acid, is an organic compound with the chemical formula C8H8O2S. It is a beige crystalline powder that exhibits unique chemical properties, making it a valuable intermediate in various chemical reactions and processes.

Uses

Used in Chemical Synthesis:
(Benzylthio)acetic acid is used as a reactant in the nickel-catalyzed cross-coupling reactions. This process involves the use of coenzyme M or thioglycolic acid as the leaving group, allowing for the formation of new chemical bonds and the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
(Benzylthio)acetic acid serves as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical properties enable the development of new drugs with potential therapeutic applications.
Used in Organic Chemistry Research:
Due to its reactivity and versatility, (benzylthio)acetic acid is utilized in organic chemistry research to explore new reaction pathways, develop innovative synthetic methods, and understand the fundamental principles of chemical reactions.

Check Digit Verification of cas no

The CAS Registry Mumber 103-46-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,0 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 103-46:
(5*1)+(4*0)+(3*3)+(2*4)+(1*6)=28
28 % 10 = 8
So 103-46-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O2S/c10-9(11)7-12-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,10,11)/p-1

103-46-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A18698)  (Benzylthio)acetic acid, 97%   

  • 103-46-8

  • 10g

  • 400.0CNY

  • Detail
  • Alfa Aesar

  • (A18698)  (Benzylthio)acetic acid, 97%   

  • 103-46-8

  • 50g

  • 1544.0CNY

  • Detail

103-46-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (BENZYLTHIO)ACETIC ACID

1.2 Other means of identification

Product number -
Other names Acetic acid, [(phenylmethyl)thio]-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103-46-8 SDS

103-46-8Relevant articles and documents

Bivalent SIRT1 inhibitors

Wang, Juan,Zang, Wenwen,Liu, Jiajia,Zheng, Weiping

, p. 180 - 186 (2017)

In the current study, bivalent compounds 1–17 constructed by covalently linking the ?-amino group of lysine in a tripeptidic scaffold to a functionality via a linker were prepared and examined for their inhibitory potencies against SIRT1, a prototypical member of the β-nicotinamide adenine dinucleotide (β-NAD+)-dependent sirtuin family of protein Nε-acyl-lysine deacylases. A few of them were found to be stronger SIRT1 inhibitors than the N?-acetyl-lysine-containing monovalent counterparts 18 and 19. As exemplified with compounds 6 and 18, a bivalent SIRT1 inhibitor could exhibit a greater degree of inhibitory selectivity among SIRT1/2/3 than the corresponding monovalent counterpart. This study has laid a foundation for the future development of superior bivalent inhibitors against the (patho)physiologically and therapeutically important sirtuin family of deacylase enzymes.

Co-production method of thionocarbamate and benzyl thioether acetic acid and application of the method

-

Paragraph 0081-0082, (2019/12/02)

The invention discloses a co-production method of thionocarbamate and benzyl thioether acetic acid and application of the method. The method comprises the following steps: with xanthate and benzyl chloride as initial raw materials, and performing esterification reaction to obtain benzyl xanthate; carrying out ammonolysis on benzyl xanthate by using primary amine to obtain thionocarbamate and benzyl mercaptan; further adding sodium chloroacetate into the mixture for reaction, thus generating benzyl thioether sodium acetate; finally, performing liquid separation to obtain the thionocarbamate collecting agent and a water phase containing benzyl thioether sodium acetate. The benzyl thioether sodium acetate-containing water phase can further react with benzyl chloride to obtain benzyl thioetherbenzyl acetate or be acidified and esterified with fatty alcohol to generate benzyl thioether alkyl acetate, and the two ester compounds can be subjected to hydroximation to synthesize benzyl thioether ethyl hydroximic acid. The method solves the problems of difficult recovery, difficult utilization and unpleasant smell of the byproduct sulfhydryl compound in the traditional thionocarbamate process, realizes co-production of benzyl thioether acetic acid and derivatives thereof, and improves the reaction efficiency.

Styryl sulfones compound, its preparation method and its use as neuroprotective agents

-

Paragraph 0059-0061, (2018/02/04)

The application relates to design of a novel molecule with ester group substituted by sulfone group by using a caffeic acid phenethyl ester (CAPE) with neuroprotective activity extracted from natural propolis as a primer according to bioisosterism principle and hydrogen-bond interaction theory; and the molecule has a structural general formula I, and the definition of each group is shown in the claims. The invention also relates to compound in vitroantioxidation capability evaluation, neuroprotective activity evaluation on cell level and traverse blood brain barrier ability evaluation. Activity evaluation results show that the synthesized novel compound has enhanced neuroprotective activity and can easily traverse the blood brain barrier, thus becoming a novel neuroprotective agent for treating neurodegenerative diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103-46-8